2025-04-14 07:16:09
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Bodal Chemicals posts consolidated PAT of Rs. 24.32 crores in Q3 FY22
Posted On : 2022-02-11 20:55:34( TIMEZONE : IST )
Bodal Chemicals Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 568.443 crores during the period ended December 31, 2021 as compared to Rs. 471.457 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 24.321 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 23.886 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 2.20 for the period ended December 31, 2021 as compared to Rs. 1.81 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 568.443 crs | ₹471.457 crs |  20.57% |
| Net Profit | ₹24.321 crs | ₹23.886 crs | 1.82% |
| EPS | ₹2.20 | ₹1.81 | 21.55% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 568.443 crores during the period ended December 31, 2021 as compared to Rs.373.159 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.24.321 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.26.512 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.2.20 for the period ended December 31, 2021 as compared to Rs.2.16 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 568.443 crs | ₹373.159 crs | 52.33% |
| Net Profit | ₹24.321 crs | ₹26.512 crs |  -8.26% |
| EPS | ₹2.20 | ₹2.16 | 1.85% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1468.084 crores during the 9 Months period ended December 31, 2021 as compared to Rs.809.765 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.76.793 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.18.410 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.6.26 for the 9 Months period ended December 31, 2021 as compared to Rs.1.50 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹1468.084 crs | ₹809.765 crs | 81.30% |
| Net Profit | ₹76.793 crs | ₹18.410 crs | 317.13% |
| EPS | ₹6.26 | ₹1.50 | 317.33% |
Shares of Bodal Chemicals Limited was last trading in BSE at Rs. 116.60 as compared to the previous close of Rs. 118.30. The total number of shares traded during the day was 141276 in over 2110 trades.
The stock hit an intraday high of Rs. 119.10 and intraday low of 115.60. The net turnover during the day was Rs. 16520503.00.
